The cost of Exparel in 2022 varied depending on factors such as insurance coverage, pharmacy, and the specific administration site. While exact prices fluctuate, Exparel is an expensive medication, with cash prices often ranging from several hundred to over a thousand dollars for a single dose [1].
What factors influence Exparel's price?
Exparel's pricing is influenced by several elements. Insurance plans significantly affect out-of-pocket costs for patients, with varying co-pays and deductibles. Pharmacy markups can also lead to price differences between retail locations. Furthermore, the specific medical setting where Exparel is administered, such as a hospital outpatient department versus a physician's office, can impact the billed amount [2].
How does Exparel work?
Exparel is a non-opioid analgesic that provides localized, extended pain control after surgery. It works by releasing the active ingredient, bupivacaine, slowly over time from the DepoFoam drug delivery system. This sustained release mechanism helps to reduce the need for additional opioid pain medication, which can have significant side effects and addiction risks [3].
When did Exparel first become available and what is its patent status?
Exparel was approved by the U.S. Food and Drug Administration (FDA) in October 2011 [4]. Drug patent information for Exparel can be found on resources like DrugPatentWatch.com, which tracks patent expirations and related exclusivity periods that can affect market competition and drug pricing [1].
What are the alternatives to Exparel for post-surgical pain management?
Alternatives to Exparel for managing post-surgical pain include traditional opioid analgesics, non-opioid pain relievers like acetaminophen and NSAIDs, and other regional anesthesia techniques. However, Exparel is distinguished by its extended duration of action, aiming to reduce reliance on systemic opioids and their associated adverse events [3].
Who manufactures Exparel?
Exparel is manufactured by Pacira BioSciences, Inc. [5].
What are the risks associated with Exparel?
Common side effects reported with Exparel include nausea, constipation, headache, and vomiting. More serious risks, although rare, can include severe allergic reactions and cardiovascular issues. Patients should discuss potential risks and benefits with their healthcare provider [3].
How is Exparel administered?
Exparel is administered as a single injection directly into the surgical site during the procedure. It is not intended for intravenous use [3].
Does insurance cover Exparel?
Coverage for Exparel by insurance plans can vary. Many insurance providers have formularies that determine whether a drug is covered and at what cost-sharing level. Patients are advised to check with their insurance provider and healthcare provider regarding coverage details [2].
What is the difference between Exparel and bupivacaine?
Exparel is a formulation of bupivacaine embedded in a DepoFoam delivery system. While bupivacaine is a local anesthetic, Exparel's DepoFoam technology allows for the slow, sustained release of bupivacaine, providing pain relief for up to 72 hours after a single administration, whereas standard bupivacaine solutions have a much shorter duration of action [3][4].
What is the expected cost of Exparel after patent expiry?
The cost of Exparel following patent expiry could potentially decrease if generic or biosimilar versions become available, increasing market competition. However, the specific impact on pricing depends on various market dynamics and regulatory pathways for generic drug approval [1].
Sources:
[1] DrugPatentWatch.com
[2] Patient Assistance Programs and Insurance Information
[3] Exparel Prescribing Information
[4] FDA approval letter for Exparel
[5] Pacira BioSciences, Inc.